NGEN (NervGen Pharma) Pretax Margin %: % (As of Mar. 2026)

What is NervGen Pharma Pretax Margin %?

NervGen Pharma NGEN -1.06% 22 Pretax Margin % is % as of Mar. 2026. GuruFocus rates NGEN with a GF Score™ of 22/100. The stock has 2 warning signs investors should review. Among 946 Biotechnology companies, NervGen Pharma ranks worse than 105708.14% on this metric.

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. NervGen Pharma's Pre-Tax Income for the three months ended in Mar. 2026 was $-1.22 Mil. NervGen Pharma's Revenue for the three months ended in Mar. 2026 was $0.00 Mil. Therefore, NervGen Pharma's pretax margin for the quarter that ended in Mar. 2026 was %.

The historical rank and industry rank for NervGen Pharma's Pretax Margin % or its related term are showing as below:

NGEN's Pretax Margin % is not ranked ^*
in the Biotechnology industry.
Industry Median: -90.5
* Ranked among companies with meaningful Pretax Margin % only.

NervGen Pharma (NAS:NGEN) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.

NervGen Pharma Pretax Margin % Related Terms

NervGen Pharma Pretax Margin % Historical Data

* Premium members only.

The historical data trend for NervGen Pharma's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NervGen Pharma Pretax Margin % Chart

NervGen Pharma Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Pretax Margin %

Get a 7-Day Free Trial

0.00

NervGen Pharma Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Pretax Margin %	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

NGEN vs CNTN, ELTX, KROS: Pretax Margin % Comparison

For the Biotechnology subindustry, NervGen Pharma's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NervGen Pharma Pretax Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, NervGen Pharma's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where NervGen Pharma's Pretax Margin % falls into.

Save Embed

22GF Score

NervGen Pharma Corp NGEN

Pretax Margin % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

NervGen Pharma Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

NervGen Pharma's Pretax Margin for the fiscal year that ended in Dec. 2025 is calculated as

Pretax Margin	=	Pre-Tax Income (A: Dec. 2025 )	/	Revenue (A: Dec. 2025 )
	=	-31.98	/	0
	=	%

NervGen Pharma's Pretax Margin for the quarter that ended in Mar. 2026 is calculated as

Pretax Margin	=	Pre-Tax Income (Q: Mar. 2026 )	/	Revenue (Q: Mar. 2026 )
	=	-1.222	/	0
	=	%

Frequently Asked Questions Learn more about Pretax Margin % →

What does a Pretax Margin % of % mean?

NervGen Pharma (NGEN) has a Pretax Margin % of % as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on NervGen Pharma and its competitors. According to the industry distribution chart, NervGen Pharma ranks #999999 out of 946 companies in the Biotechnology industry.

Is NervGen Pharma's Pretax Margin % too high?

NervGen Pharma's current Pretax Margin % is %. Based on the distribution chart, NervGen Pharma ranks #999999 out of 946 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, NervGen Pharma has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.

How does NervGen Pharma's Pretax Margin % compare to CNTN and ELTX?

According to the Biotechnology industry distribution chart, NervGen Pharma ranks #999999 out of 946 companies for Pretax Margin %. This places NervGen Pharma in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Pretax Margin % for a Biotechnology company?

A good Pretax Margin % depends on the Biotechnology industry context. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Pretax Margin % mean?

A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on NervGen Pharma and its competitors. NervGen Pharma's current Pretax Margin % is %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is NervGen Pharma stock overvalued right now?

NervGen Pharma (NGEN) has a current Pretax Margin % of %. The current Pretax Margin % is %. NervGen Pharma's overall GF Score™ is 22/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Pretax Margin % calculated?

Pretax Margin % is calculated from a company's financial statements. For NervGen Pharma (NGEN), the current Pretax Margin % is % as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

NervGen Pharma Business Description

Industry Healthcare Biotechnology

Comparable Companies CNTN ELTX KROS RNA RNAC NBP ARCT INDP YDES NERV VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY RVMD ASX:CSL ONC XKRX:068270

Other Exchanges 9UA:Germany

Address 112-970 Burrard Street, Unit 1290, Vancouver, BC, CAN, V6Z 2R4

Website https://www.nervgen.com

NervGen Pharma Corp is a clinical-stage biopharmaceutical company developing first-in-class neuroreparative therapeutics for spinal cord injury and other traumatic and neurologic conditions. The Company's principal business activity is the discovery, development and commercialization of neuroreparative therapeutics for spinal cord injury (SCI) and other neurotraumatic and neurologic conditions. NervGen's initial target indication is SCI. The company's pipeline products include NVG-291 and NVG-300.

22GF Score

Get the complete analysis for NGEN

Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.87

Price

View NGEN Analysis

See Pretax Margin % data for all stocks →